Punjab HM Bats For Bringing Parity In Prices Of Same Salt Medicines

Chandigarh: With an aim to ensure affordable medicines for millions of people in the country, Health and Family Welfare Minister Dr Balbir Singh on Monday raised the issue regarding the disparity of prices of same salts of medicines available in the market with different brand names.

The Health Minister was addressing the inaugural session of three-days 4th Regional Training Programme on “Capacity Building of Drug Regulators of Northern States” organised by Central Drugs Standards Control Organization (CDSCO), Ministry of Health & Family Welfare, Government of India in collaboration with Food and Drugs Administration (FDA), Government of Punjab at Hotel Parkview here. Joint Drugs Controller (India) Dr S Eswara Reddy, Secretary Health-cum-Commissioner Food and Drugs Administration Punjab Dr Abhinav Trikha and Joint Commissioner (Drugs) FDA Punjab Sanjiv Kumar were also present.

While stressing on the need to bring parity in the prices of all the medicines, Dr Balbir Singh said that these issues need attention of the Central Government. “I’ve already flagged this issue with the Union Health Minister,” he added.

The Health Minister also raised the concern regarding quality of drugs available in the market and urged the Joint Drugs Controller (India) to make some concrete policy to tackle the issue.

He said that the Indian pharmaceutical industry has contributed significantly to global healthcare by ensuring high quality, affordable and accessible medicines around the world. India is known as the pharmacy of the world for quality generic affordable medical products, he added.

“India is the third largest producer of generic drugs in terms of volume and 10th in terms of value. Almost every 5th pill used by the patients in the world is manufactured in India,” said Dr Balbir Singh.

Commissioner FDA Punjab Dr Abhinav Trikha stressed on the need to develop a dedicated platform to address the various common issues of States with Government of India including online licensing, quality of drugs and regulatory enforcement for better implementation of the provisions of Drugs & Cosmetics Act/Rules.

He also emphasised on the importance of such training programmes for skill and personality development of the enforcement officers and urged CDSCO to arrange such events on a regular basis.

Meanwhile, this three days Residential Training Programme is being organized for 75 Drugs Control Officers from Punjab, Jammu and Kashmir, Uttrakhand, Himachal Pradesh and Chandigarh for capacity building of Drugs Regulators. During this training, various eminent key speakers including JDC (I), CDSCO (HQ), New Delhi Dr SE Reddy, Ex Drugs Controller Odisha Hrushikesh Mahapatra, Associate Director-Quality Operation Head, M/s Cipla Ltd. Sourav Ghosh, DGM – Site Quality Assurance, M/s Sun Pharma Rishi Kansara, and other Officers from NPPA will be holding training sessions for the participants.

Related Posts

Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

New Delhi: Even as global economic uncertainty drags down trade, Indian pharmaceutical exporters are seeing growth in Brazil and Nigeria as both countries are emerging as important overseas markets. Data…

UP has emerged as India’s largest Healthcare & med tech hub: Yogi

Lucknow: Chief Minister Yogi Adityanath on Sunday said that Uttar Pradesh is not merely a state with a population of 25 crore but has also emerged as the country’s largest hub…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

UP has emerged as India’s largest Healthcare & med tech hub: Yogi

UP has emerged as India’s largest Healthcare & med tech hub: Yogi

Centre flags serious lapses in state’s blood banks

Centre flags serious lapses in state’s blood banks

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Controlled substances charge: Court summons Ramdev, Amazon founder

Controlled substances charge: Court summons Ramdev, Amazon founder